首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1693076

空間基因組學和轉錄組學市場 2025-2029

Global Spatial Genomics and Transcriptomics Market 2025-2029

出版日期: 2025年03月21日 | 出版商:

TechNavio | 英文 199 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計 2024 年至 2029 年期間空間基因組學和轉錄組學市場將成長 7.323 億美元，預測期內複合年成長率為 12%。

本報告對空間基因組學和轉錄組學市場進行了全面的分析，包括市場規模、預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場情景、最新趨勢和促進因素以及整體市場環境的最新分析。市場受到藥物發現中空間基因組學的應用、供應商產品發布和戰略合作數量的增加以及空間體學作為技術主導領域的出現所推動。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
2025與前一年同期比較	9.9%
複合年成長率	12%
增量金額	7.323億美元

研究採用客觀結合一手資料和二手資料的方式進行，其中包括來自業界主要參與者的意見。該報告包括全面的市場規模資料（按地理分析細分）和供應商格局以及對主要企業的分析。報告包括資料和預測資料。

研究指出，空間體學在生物標記識別的應用日益廣泛，是推動未來幾年空間基因組學和轉錄組學市場成長的關鍵原因之一。此外，癌症診斷中空間基因組分析的新可能性和定序技術的進步將導致市場需求龐大。

地理細分
區域比較
北美：2024-2029 年市場規模及預測
歐洲：2024-2029 年市場規模及預測
亞洲：2024-2029 年市場規模及預測
世界其他地區：2024-2029 年市場規模及預測
美國：市場規模及預測（2024-2029）
德國：2024-2029年市場規模及預測
中國：2024-2029年市場規模及預測
英國：2024-2029 年市場規模及預測
加拿大：2024-2029 年市場規模及預測
墨西哥：2024-2029 年市場規模及預測
日本：2024-2029 年市場規模及預測
印度：2024-2029 年市場規模及預測
法國：2024-2029年市場規模及預測
巴西：2024-2029 年市場規模及預測
按地區分類的市場機會

第12章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第13章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第14章競爭分析

公司簡介
企業排名指數
公司市場定位
Akoya Biosciences Inc.
Bio Rad Laboratories Inc.
Bio Techne Corp.
Fulgent Genetics Inc.
Illumina Inc.
Lunaphore Technologies SA
NanoString Technologies Inc.
Perkin Elmer Inc.
RareCyte Inc
Rebus Biosystems Inc
Resolve BioSciences GmbH
S2 Genomic Inc
Seven Bridges Genomics Inc.
Veranome Biosystems LLC

第15章附錄

簡介目錄圖表

Product Code: IRTNTR73547

The spatial genomics and transcriptomics market is forecasted to grow by USD 732.3 million during 2024-2029, accelerating at a CAGR of 12% during the forecast period. The report on the spatial genomics and transcriptomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by adoption of spatial genomics in drug discovery, rising product launches and strategic alliances by vendors, and emergence of spatial omics as a technology-driven field.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	9.9%
CAGR	12%
Incremental Value	$732.3 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's spatial genomics and transcriptomics market is segmented as below:

By Product

Consumables
Instruments

By End-user

Translational research
Academic customers
Diagnostic customers
Pharmaceutical manufacturer

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing use of spatial omics for biomarker identification as one of the prime reasons driving the spatial genomics and transcriptomics market growth during the next few years. Also, emerging potential of spatial genomics analysis in cancer diagnostics and advances in sequencing technologies will lead to sizable demand in the market.

The report on the spatial genomics and transcriptomics market covers the following areas:

Spatial Genomics And Transcriptomics Market sizing
Spatial Genomics And Transcriptomics Market forecast
Spatial Genomics And Transcriptomics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spatial genomics and transcriptomics market vendors that include 10X Genomics Inc., Akoya Biosciences Inc., Bio RAD Laboratories Inc., Bio Techne Corp., BioSpyder Technologies Inc., Cantata Bio LLC, Fulgent Genetics Inc., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., Perkin Elmer Inc., RareCyte Inc, Rebus Biosystems Inc, Resolve BioSciences GmbH, S2 Genomic Inc, Seven Bridges Genomics Inc., Singular Genomics System Inc, Ultivue Inc., Veranome Biosystems LLC, and Vizgen Corp. Also, the spatial genomics and transcriptomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Spatial Genomics And Transcriptomics Market 2019 - 2023
- Historic Market Size - Data Table on Global Spatial Genomics And Transcriptomics Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Spatial Genomics and Transcriptomics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Consumables - Market size and forecast 2024-2029
- Chart on Consumables - Market size and forecast 2024-2029 ($ million)
- Data Table on Consumables - Market size and forecast 2024-2029 ($ million)
- Chart on Consumables - Year-over-year growth 2024-2029 (%)
- Data Table on Consumables - Year-over-year growth 2024-2029 (%)
8.4 Instruments - Market size and forecast 2024-2029
- Chart on Instruments - Market size and forecast 2024-2029 ($ million)
- Data Table on Instruments - Market size and forecast 2024-2029 ($ million)
- Chart on Instruments - Year-over-year growth 2024-2029 (%)
- Data Table on Instruments - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Translational research - Market size and forecast 2024-2029
- Chart on Translational research - Market size and forecast 2024-2029 ($ million)
- Data Table on Translational research - Market size and forecast 2024-2029 ($ million)
- Chart on Translational research - Year-over-year growth 2024-2029 (%)
- Data Table on Translational research - Year-over-year growth 2024-2029 (%)
9.4 Academic customers - Market size and forecast 2024-2029
- Chart on Academic customers - Market size and forecast 2024-2029 ($ million)
- Data Table on Academic customers - Market size and forecast 2024-2029 ($ million)
- Chart on Academic customers - Year-over-year growth 2024-2029 (%)
- Data Table on Academic customers - Year-over-year growth 2024-2029 (%)
9.5 Diagnostic customers - Market size and forecast 2024-2029
- Chart on Diagnostic customers - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostic customers - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostic customers - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic customers - Year-over-year growth 2024-2029 (%)
9.6 Pharmaceutical manufacturer - Market size and forecast 2024-2029
- Chart on Pharmaceutical manufacturer - Market size and forecast 2024-2029 ($ million)
- Data Table on Pharmaceutical manufacturer - Market size and forecast 2024-2029 ($ million)
- Chart on Pharmaceutical manufacturer - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceutical manufacturer - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.11 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.12 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
11.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
11.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
- 10X Genomics Inc.
- 10X Genomics Inc. - Overview
- 10X Genomics Inc. - Product / Service
- 10X Genomics Inc. - Key offerings
- SWOT
14.5 Akoya Biosciences Inc.
- Akoya Biosciences Inc. - Overview
- Akoya Biosciences Inc. - Product / Service
- Akoya Biosciences Inc. - Key offerings
- SWOT
14.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
14.7 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
14.8 Fulgent Genetics Inc.
- Fulgent Genetics Inc. - Overview
- Fulgent Genetics Inc. - Product / Service
- Fulgent Genetics Inc. - Key offerings
- SWOT
14.9 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
14.10 Lunaphore Technologies SA
- Lunaphore Technologies SA - Overview
- Lunaphore Technologies SA - Product / Service
- Lunaphore Technologies SA - Key offerings
- SWOT
14.11 NanoString Technologies Inc.
- NanoString Technologies Inc. - Overview
- NanoString Technologies Inc. - Product / Service
- NanoString Technologies Inc. - Key offerings
- SWOT
14.12 Perkin Elmer Inc.
- Perkin Elmer Inc. - Overview
- Perkin Elmer Inc. - Business segments
- Perkin Elmer Inc. - Key offerings
- Perkin Elmer Inc. - Segment focus
- SWOT
14.13 RareCyte Inc
- RareCyte Inc - Overview
- RareCyte Inc - Product / Service
- RareCyte Inc - Key offerings
- SWOT
14.14 Rebus Biosystems Inc
- Rebus Biosystems Inc - Overview
- Rebus Biosystems Inc - Product / Service
- Rebus Biosystems Inc - Key offerings
- SWOT
14.15 Resolve BioSciences GmbH
- Resolve BioSciences GmbH - Overview
- Resolve BioSciences GmbH - Product / Service
- Resolve BioSciences GmbH - Key offerings
- SWOT
14.16 S2 Genomic Inc
- S2 Genomic Inc - Overview
- S2 Genomic Inc - Product / Service
- S2 Genomic Inc - Key offerings
- SWOT
14.17 Seven Bridges Genomics Inc.
- Seven Bridges Genomics Inc. - Overview
- Seven Bridges Genomics Inc. - Product / Service
- Seven Bridges Genomics Inc. - Key offerings
- SWOT
14.18 Veranome Biosystems LLC
- Veranome Biosystems LLC - Overview
- Veranome Biosystems LLC - Product / Service
- Veranome Biosystems LLC - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Spatial Genomics And Transcriptomics Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Product - Market share 2024-2029 (%)
Exhibits37: Data Table on Product - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Product
Exhibits39: Data Table on Comparison by Product
Exhibits40: Chart on Consumables - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Consumables - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Consumables - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Consumables - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Instruments - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Instruments - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Instruments - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Instruments - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by Product ($ million)
Exhibits49: Data Table on Market opportunity by Product ($ million)
Exhibits50: Chart on End-user - Market share 2024-2029 (%)
Exhibits51: Data Table on End-user - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by End-user
Exhibits53: Data Table on Comparison by End-user
Exhibits54: Chart on Translational research - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Translational research - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Translational research - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Translational research - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Academic customers - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Academic customers - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Academic customers - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Academic customers - Year-over-year growth 2024-2029 (%)
Exhibits62: Chart on Diagnostic customers - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Diagnostic customers - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Diagnostic customers - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Diagnostic customers - Year-over-year growth 2024-2029 (%)
Exhibits66: Chart on Pharmaceutical manufacturer - Market size and forecast 2024-2029 ($ million)
Exhibits67: Data Table on Pharmaceutical manufacturer - Market size and forecast 2024-2029 ($ million)
Exhibits68: Chart on Pharmaceutical manufacturer - Year-over-year growth 2024-2029 (%)
Exhibits69: Data Table on Pharmaceutical manufacturer - Year-over-year growth 2024-2029 (%)
Exhibits70: Market opportunity by End-user ($ million)
Exhibits71: Data Table on Market opportunity by End-user ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits133: Market opportunity By Geographical Landscape ($ million)
Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits135: Impact of drivers and challenges in 2024 and 2029
Exhibits136: Overview on criticality of inputs and factors of differentiation
Exhibits137: Overview on factors of disruption
Exhibits138: Impact of key risks on business
Exhibits139: Companies covered
Exhibits140: Company ranking index
Exhibits141: Matrix on companies position and classification
Exhibits142: 10X Genomics Inc. - Overview
Exhibits143: 10X Genomics Inc. - Product / Service
Exhibits144: 10X Genomics Inc. - Key offerings
Exhibits145: SWOT
Exhibits146: Akoya Biosciences Inc. - Overview
Exhibits147: Akoya Biosciences Inc. - Product / Service
Exhibits148: Akoya Biosciences Inc. - Key offerings
Exhibits149: SWOT
Exhibits150: Bio Rad Laboratories Inc. - Overview
Exhibits151: Bio Rad Laboratories Inc. - Business segments
Exhibits152: Bio Rad Laboratories Inc. - Key news
Exhibits153: Bio Rad Laboratories Inc. - Key offerings
Exhibits154: Bio Rad Laboratories Inc. - Segment focus
Exhibits155: SWOT
Exhibits156: Bio Techne Corp. - Overview
Exhibits157: Bio Techne Corp. - Business segments
Exhibits158: Bio Techne Corp. - Key news
Exhibits159: Bio Techne Corp. - Key offerings
Exhibits160: Bio Techne Corp. - Segment focus
Exhibits161: SWOT
Exhibits162: Fulgent Genetics Inc. - Overview
Exhibits163: Fulgent Genetics Inc. - Product / Service
Exhibits164: Fulgent Genetics Inc. - Key offerings
Exhibits165: SWOT
Exhibits166: Illumina Inc. - Overview
Exhibits167: Illumina Inc. - Business segments
Exhibits168: Illumina Inc. - Key news
Exhibits169: Illumina Inc. - Key offerings
Exhibits170: Illumina Inc. - Segment focus
Exhibits171: SWOT
Exhibits172: Lunaphore Technologies SA - Overview
Exhibits173: Lunaphore Technologies SA - Product / Service
Exhibits174: Lunaphore Technologies SA - Key offerings
Exhibits175: SWOT
Exhibits176: NanoString Technologies Inc. - Overview
Exhibits177: NanoString Technologies Inc. - Product / Service
Exhibits178: NanoString Technologies Inc. - Key offerings
Exhibits179: SWOT
Exhibits180: Perkin Elmer Inc. - Overview
Exhibits181: Perkin Elmer Inc. - Business segments
Exhibits182: Perkin Elmer Inc. - Key offerings
Exhibits183: Perkin Elmer Inc. - Segment focus
Exhibits184: SWOT
Exhibits185: RareCyte Inc - Overview
Exhibits186: RareCyte Inc - Product / Service
Exhibits187: RareCyte Inc - Key offerings
Exhibits188: SWOT
Exhibits189: Rebus Biosystems Inc - Overview
Exhibits190: Rebus Biosystems Inc - Product / Service
Exhibits191: Rebus Biosystems Inc - Key offerings
Exhibits192: SWOT
Exhibits193: Resolve BioSciences GmbH - Overview
Exhibits194: Resolve BioSciences GmbH - Product / Service
Exhibits195: Resolve BioSciences GmbH - Key offerings
Exhibits196: SWOT
Exhibits197: S2 Genomic Inc - Overview
Exhibits198: S2 Genomic Inc - Product / Service
Exhibits199: S2 Genomic Inc - Key offerings
Exhibits200: SWOT
Exhibits201: Seven Bridges Genomics Inc. - Overview
Exhibits202: Seven Bridges Genomics Inc. - Product / Service
Exhibits203: Seven Bridges Genomics Inc. - Key offerings
Exhibits204: SWOT
Exhibits205: Veranome Biosystems LLC - Overview
Exhibits206: Veranome Biosystems LLC - Product / Service
Exhibits207: Veranome Biosystems LLC - Key offerings
Exhibits208: SWOT
Exhibits209: Inclusions checklist
Exhibits210: Exclusions checklist
Exhibits211: Currency conversion rates for US$
Exhibits212: Research methodology
Exhibits213: Information sources
Exhibits214: Data validation
Exhibits215: Validation techniques employed for market sizing
Exhibits216: Data synthesis
Exhibits217: 360 degree market analysis
Exhibits218: List of abbreviations